Description
STYLAGE XL Bisoft 2X1ml – Facial Volume Restoration Filler
STYLAGE XL Bisoft 2X1ml Cross-Linked Hyaluronic Acid Filler by Vivacy for Cheeks, Chin & Jawline Contouring
Product Overview of STYLAGE XL Bisoft 2X1ml
STYLAGE XL Bisoft 2X1ml is a high-viscosity hyaluronic acid dermal filler manufactured by Laboratoires Vivacy in France, specifically formulated for restoring facial volume lost over time. Designed to address significant volume loss and enhance facial contours, this filler is well suited for reshaping areas such as the cheeks, temples, chin, and jawline — delivering a fuller, softer, more youthful facial appearance without the added lidocaine anesthetic found in the sister formulation.
STYLAGE XL Bisoft 2X1ml Each box contains two pre-filled 1ml syringes of cross-linked hyaluronic acid gel, developed using Vivacy’s patented IPN-Like (Interpenetrating Polymer Network) cross-linking technology and delivered through the brand’s ergonomic Bi-Soft injection system.
Key Features of STYLAGE XL Bisoft 2X1ml
- Volume: 2 x 1ml pre-filled syringes per box
- Manufacturer: Laboratoires Vivacy, France
- Formulation: Cross-linked hyaluronic acid, 26mg/g concentration
- Antioxidant: Enriched with mannitol to help protect against oxidative stress and extend results
- Injection System: Vivacy’s patented Bi-Soft syringe for enhanced precision and reduced injection pressure
- Injection Depth: Deep dermis or subcutaneous tissue
How STYLAGE XL Bi-Soft Works
Facial volume loss is one of the primary contributors to visible skin aging, leading to hollowed cheeks, temples, and a less defined jawline. STYLAGE XL uses a high-viscosity, monophasic hyaluronic acid gel built on Vivacy’s IPN-Like cross-linking technology, giving it the structural strength needed to restore and augment facial volume while still integrating smoothly with surrounding tissue for a natural feel.
The formula’s mannitol content acts as an antioxidant, helping protect the hyaluronic acid from free radical damage and slow its natural breakdown in the skin — supporting longer-lasting results. The Bi-Soft syringe system, made of soft-touch polycarbonate, is designed to reduce the pressure needed during injection, improving precision for the practitioner and comfort for the patient even without a built-in anesthetic.
Benefits
- Restores significant facial volume lost due to aging or weight loss
- Recontours cheeks, cheekbones, chin, and jawline
- Improves facial harmony and balance
- Helps treat skin laxity and mild sagging
- High-viscosity formula for structural, long-lasting support
- Natural-looking, immediate results
- Longer-lasting effects thanks to mannitol’s antioxidant properties
- Results commonly last 12–18 months, depending on the individual
Common Treatment Areas
STYLAGE XL Bi-Soft is commonly used for:
- Cheek and cheekbone volumizing
- Temple volume restoration
- Chin and jawline contouring
- Correction of hollow facial areas caused by aging or weight loss
- Mild to moderate facial sagging (ptosis)
- General facial contour restoration
Why Choose STYLAGE XL Bi-Soft?
- Strong structural support: High-viscosity gel purpose-built for significant volume correction
- Precise application: Ergonomic Bi-Soft syringe improves control and reduces injection pressure
- Extended longevity: Mannitol antioxidant content helps slow hyaluronic acid breakdown over time
- Trusted French manufacturing: Produced by Vivacy using patented IPN-Like cross-linking technology
- Versatile correction: Effective across multiple structural facial zones in a single treatment
- Efficient results: Often just one or two sessions are needed for noticeable volume restoration, particularly in the cheeks
Important Usage Notes
STYLAGE XL Bi-Soft is a medical device intended strictly for administration by licensed, trained healthcare professionals, injected into the deep dermis or subcutaneous tissue. It should be avoided in patients with autoimmune conditions, those who are pregnant or breastfeeding, or those with known hypersensitivity to hyaluronic acid. It should not be injected into areas with thin skin, such as the periorbital region, or in patients prone to hypertrophic scarring. Patients are generally advised to avoid aspirin, NSAIDs, or anticoagulants for one week prior to injection, and to apply high-SPF sunscreen for at least two weeks following treatment. Product information is provided for professional and cosmetic reference only and is not intended to diagnose, treat, cure, or prevent any medical condition.
